| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |